Alector (ALEC) Total Non-Current Liabilities (2018 - 2026)

Alector (ALEC) reported Total Non-Current Liabilities of $227.8 million for Q1 2026, down 27.07% year-over-year from $312.3 million in Q1 2025, and down 12.68% quarter-over-quarter from $260.9 million in Q4 2025.

Alector (ALEC) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Total Non-Current Liabilities data on file, last reported at $227.8 million in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $227.8 million, down 27.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $227.8 million (down 27.07% YoY), and the FY2025 annual result was $260.9 million, down 23.34% from the prior year.
  • Total Non-Current Liabilities retreated to $227.8 million in Q1 2026 per ALEC's latest filing, from $260.9 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $686.8 million in Q1 2022 and troughed at $227.8 million in Q1 2026.
  • A 5-year average of $440.4 million and a median of $455.2 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities surged 223.37% in 2022, then tumbled 32.25% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $572.4 million in 2022, then dropped by 15.05% to $486.3 million in 2023, then plunged by 30.03% to $340.3 million in 2024, then retreated by 23.34% to $260.9 million in 2025, then retreated by 12.68% to $227.8 million in 2026.
  • Business Quant data shows ALEC's Total Non-Current Liabilities at $227.8 million in Q1 2026, $260.9 million in Q4 2025, and $276.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Alector 193.53 Mn -12.98 Mn - 227.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 227.76 Mn
Dec 31, 2025 260.85 Mn
Sep 30, 2025 276.13 Mn
Jun 30, 2025 283.80 Mn
Mar 31, 2025 312.30 Mn
Dec 31, 2024 340.27 Mn
Sep 30, 2024 395.86 Mn
Jun 30, 2024 418.93 Mn
Mar 31, 2024 455.21 Mn
Dec 31, 2023 486.30 Mn
Sep 30, 2023 508.94 Mn
Jun 30, 2023 511.53 Mn
Mar 31, 2023 564.43 Mn
Dec 31, 2022 572.45 Mn
Sep 30, 2022 583.70 Mn
Jun 30, 2022 600.92 Mn
Mar 31, 2022 686.76 Mn
Dec 31, 2021 513.78 Mn
Sep 30, 2021 518.18 Mn
Jun 30, 2021 212.44 Mn